Search Results - "Miki, Yuichiro"

Refine Results
  1. 1

    Numerical assessment of the applicability of geometry-based force inference on homogeneous and heterogeneous cells by Miyasaka, Shou, Izumi, Keita, Okuda, Satoru, Miki, Yuichiro

    Published in PloS one (16-04-2024)
    “…The measurement of cellular forces, which reflect crucial biological attributes, has the potential to replace conventional cell assessment methods, such as…”
    Get full text
    Journal Article
  2. 2

    CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells by Miki, Yuichiro, Yashiro, Masakazu, Okuno, Tomohisa, Kitayama, Kishu, Masuda, Go, Hirakawa, Kosei, Ohira, Masaichi

    Published in British journal of cancer (20-03-2018)
    “…Background: Crosstalk between cancer cells and fibroblasts is crucial for tumour progression. It has been reported that exosomes derived from cancer cells play…”
    Get full text
    Journal Article
  3. 3

    Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer by Miki, Yuichiro, Yashiro, Masakazu, Okuno, Tomohisa, Kuroda, Kenji, Togano, Shingo, Hirakawa, Kosei, Ohira, Masaichi

    Published in PloS one (17-09-2018)
    “…It has been reported that CD63, an exosome marker, is expressed in solid cancer tissues. However, its significance in patients with gastric cancer has not been…”
    Get full text
    Journal Article
  4. 4

    Prognostic impact of postoperative systemic inflammatory response in patients with stage II/III gastric cancer by Kuroda, Kenji, Toyokawa, Takahiro, Miki, Yuichiro, Yoshii, Mami, Tamura, Tatsuro, Tanaka, Hiroaki, Lee, Shigeru, Muguruma, Kazuya, Yashiro, Masakazu, Ohira, Masaichi

    Published in Scientific reports (22-02-2022)
    “…This study examined whether the systemic inflammatory response present in the early phase of the postoperative state correlates with long-term outcomes and to…”
    Get full text
    Journal Article
  5. 5

    Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer by Yashiro, Masakazu, Kuroda, Kenji, Masuda, Go, Okuno, Tomohisa, Miki, Yuichiro, Yamamoto, Yurie, Sera, Tomohiro, Sugimoto, Atsushi, Kushiyama, Shuhei, Nishimura, Sadaaki, Togano, Shingo, Ohira, Masaichi

    Published in Scientific reports (25-02-2021)
    “…Fibroblast growth factor receptor 2 (FGFR2) has two isoforms: IIIb type and IIIc type. Clinicopathologic significance of these two FGFR2 subtypes in gastric…”
    Get full text
    Journal Article
  6. 6

    Gastric cancer stem cells survive in stress environments via their autophagy system by Togano, Shingo, Yashiro, Masakazu, Masuda, Go, Sugimoto, Atsushi, Miki, Yuichiro, Yamamoto, Yurie, Sera, Tomohiro, Kushiyama, Shuhei, Nishimura, Sadaaki, Kuroda, Kenji, Okuno, Tomohisa, Ohira, Masaichi

    Published in Scientific reports (19-10-2021)
    “…Cancer stem cells (CSCs) play an important role in the progression of carcinoma and have a high potential for survival in stress environments. However, the…”
    Get full text
    Journal Article
  7. 7

    Significance of the geriatric nutritional risk index and neutrophil-to-lymphocyte ratio as prognostic indicators in older patients with gastric cancer: a retrospective cohort study by Miyamoto, Hironari, Toyokawa, Takahiro, Ishidate, Takemi, Kuroda, Kenji, Miki, Yuichiro, Yoshii, Mami, Tamura, Tatsuro, Lee, Shigeru, Maeda, Kiyoshi

    Published in BMC cancer (13-11-2024)
    “…Background The number of older patients with cancer is increasing with the progression of aging societies. In the current study, we sought to clarify the…”
    Get full text
    Journal Article
  8. 8

    Tertiary lymphoid structures show infiltration of effective tumor‐resident T cells in gastric cancer by Mori, Takuya, Tanaka, Hiroaki, Suzuki, Shugo, Deguchi, Sota, Yamakoshi, Yoshihito, Yoshii, Mami, Miki, Yuichiro, Tamura, Tatsuro, Toyokawa, Takahiro, Lee, Shigeru, Muguruma, Kazuya, Wanibuchi, Hideki, Ohira, Masaichi

    Published in Cancer science (01-05-2021)
    “…Several studies have reported that tissue‐resident memory T cells (TRM cells) or tertiary lymphoid structures (TLSs) are associated with a good prognosis. The…”
    Get full text
    Journal Article
  9. 9

    Significance of CD103+ tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer by Natsuki, Seiji, Tanaka, Hiroaki, Nishiyama, Masaki, Deguchi, Sota, Miki, Yuichiro, Yoshii, Mami, Tamura, Tatsuro, Toyokawa, Takahiro, Lee, Shigeru, Maeda, Kiyoshi

    Published in BMC cancer (20-10-2023)
    “…Abstract Background Immune checkpoint inhibitors (ICIs), including nivolumab, have been approved to treat esophageal cancer. However, these remedies are not…”
    Get full text
    Journal Article
  10. 10

    The Optimal Definition of Sarcopenia for Predicting Postoperative Pneumonia after Esophagectomy in Patients with Esophageal Cancer by Nambara, Mikio, Miki, Yuichiro, Tamura, Tatsuro, Yoshii, Mami, Toyokawa, Takahiro, Tanaka, Hiroaki, Lee, Shigeru, Muguruma, Kazuya, Shibata, Toshihiko, Ohira, Masaichi

    Published in World journal of surgery (01-10-2021)
    “…Background Esophageal cancer (EC) is associated with malnutrition in the vast majority of patients, and this often leads to sarcopenia, which is characterised…”
    Get full text
    Journal Article
  11. 11

    Clinical efficacy of nivolumab is associated with tertiary lymphoid structures in surgically resected primary tumors of recurrent gastric cancer by Mori, Takuya, Tanaka, Hiroaki, Deguchi, Sota, Yamakoshi, Yoshihito, Miki, Yuichiro, Yoshii, Mami, Tamura, Tatsuro, Toyokawa, Takahiro, Lee, Shigeru, Muguruma, Kazuya, Ohira, Masaichi

    Published in PloS one (07-01-2022)
    “…Nivolumab, an immune checkpoint blocker, has been approved for advanced gastric cancer (GC), but predictive factors of nivolumab's efficacy in patients with…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Risk factors for postoperative pneumonia after gastrectomy for gastric cancer by Miki, Yuichiro, Makuuchi, Rie, Tokunaga, Masanori, Tanizawa, Yutaka, Bando, Etsuro, Kawamura, Taiichi, Terashima, Masanori

    Published in Surgery today (Tokyo, Japan) (01-05-2016)
    “…Purpose The number of elderly patients undergoing gastrectomy for gastric cancer is increasing. Yet, although elderly patients are at high risk of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer by Miki, Yuichiro, Yashiro, Masakazu, Moyano-Galceran, Lidia, Sugimoto, Atsushi, Ohira, Masaichi, Lehti, Kaisa

    Published in Frontiers in oncology (16-10-2020)
    “…Gastric cancer (GC) is the third leading cause among all cancer deaths globally. Although the treatment outcome of GC has improved, the survival of patients…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Prognostic relevance of tumor‐resident memory T cells in metastatic lymph nodes of esophageal squamous cell carcinoma by Natsuki, Seiji, Tanaka, Hiroaki, Nishiyama, Masaki, Mori, Takuya, Deguchi, Sota, Miki, Yuichiro, Yoshii, Mami, Tamura, Tatsuro, Toyokawa, Takahiro, Lee, Shigeru, Maeda, Kiyoshi

    Published in Cancer science (01-05-2023)
    “…Tumor‐resident memory T (TRM) cells in primary tumors are reportedly associated with a favorable prognosis in several malignancies. However, the behaviors and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma by Deguchi, Sota, Tanaka, Hiroaki, Suzuki, Shugo, Natsuki, Seji, Mori, Takuya, Miki, Yuichiro, Yoshii, Mami, Tamura, Tatsuro, Toyokawa, Takahiro, Lee, Shigeru, Muguruma, Kazuya, Wanibuchi, Hideki, Ohira, Masaichi

    Published in BMC cancer (24-06-2022)
    “…Abstract Background Tertiary lymphoid structures (TLSs) have been reported to be involved in immune responses in many carcinomas. This study investigated the…”
    Get full text
    Journal Article
  20. 20

    Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor by Kuroda, Kenji, Yashiro, Masakazu, Miki, Yuichiro, Sera, Tomohiro, Yamamoto, Yurie, Sugimoto, Atsushi, Nishimura, Sadaaki, Kushiyama, Shuhei, Togano, Shingo, Okuno, Tomohisa, Ohira, Masaichi

    Published in Cancer science (01-12-2020)
    “…Fibroblast growth factor receptor (FGFR) is associated with proliferation, migration, and angiogenesis of carcinomas, and FGFR signaling inhibitors are…”
    Get full text
    Journal Article